Axonal damage: A key predictor of outcome in human CNS diseases

Brain

Volumn 126, Issue 3, 2003, Pages 515-530

  Medana, I M ^a   Esiri, M M ^a,b,c  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^c RADCLIFFE INFIRMARY   (United Kingdom)

Author keywords

Acute haemorrhagic encephalitis; Axonal damage; Cerebral malaria; HIV encephalitis; Multiple sclerosis; Neuropathology; Vascular dementia

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; CALPASTATIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; BRAIN ISCHEMIA; CENTRAL NERVOUS SYSTEM DISEASE; CENTRAL PONTINE MYELINOLYSIS; CLINICAL FEATURE; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG MECHANISM; DRUG TARGETING; HEAD INJURY; HTLV 1 ASSOCIATED MYELOPATHY; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; LEUKODYSTROPHY; MALARIA; METABOLIC ENCEPHALOPATHY; MULTIPLE SCLEROSIS; NERVE FIBER DEGENERATION; NEUROPROTECTION; PATHOGENESIS; PREDICTION; PRIORITY JOURNAL; REVIEW; SPINAL CORD DISEASE; SPINAL CORD INJURY;

ADOLESCENT; ADULT; AGED; AIDS DEMENTIA COMPLEX; AXONS; BRAIN DISEASES, METABOLIC; BRAIN ISCHEMIA; CENTRAL NERVOUS SYSTEM DISEASES; CHILD; CHILD, PRESCHOOL; CRANIOCEREBRAL TRAUMA; DELTARETROVIRUS INFECTIONS; DEMYELINATING DISEASES; DIFFUSE AXONAL INJURY; HIV-1; HUMANS; INFANT; MALARIA, CEREBRAL; MIDDLE AGED; MULTIPLE SCLEROSIS; SPINAL CORD INJURIES;

EID: 0037370914     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/awg061     Document Type: Review

References (143)

1. Adams JH, Doyle D, Ford I, Gennarelli TA, Graham DI, McLellan DR. Diffuse axonal injury in head injury: definition, diagnosis and grading. Histopathology 1989; 15: 49-59.
2. Adams JH, Jennett B, McLellan DR, Murray LS, Graham DI. The neuropathology of the vegetative state after head injury. J Clin Pathol 1999; 52: 804-6.
3. Adams JH, Graham DI, Jennett B. The structural basis of moderate disability after traumatic brain damage. J Neurol Neurosurg Psychiatry 2001; 71: 521-4.
4. Adle-Biassette H, Chretien F, Wingertsmann L, Hery C, Ereau T, Scaravilli F, et al. Neuronal apoptosis does not correlate with dementia in HIV infection but is related to microglial activation and axonal damage. Neuropathol Appl Neurobiol 1999; 25: 123-33.
5. Ahlgren S, Li GL, Olsson Y. Accumulation of beta-amyloid precursor protein and ubiquitin in axons after spinal cord trauma in humans: immunohistochemical observations on autopsy material. Acta Neuropathol (Berl) 1996; 92: 49-55.
6. Ahmed SM, Rzigalinski BA, Willoughby KA, Sitterding HA, Ellis EF. Stretch-induced injury alters mitochondrial membrane potential and cellular ATP in cultured astrocytes and neurons. J Neurochem 2000; 74: 1951-60.
7. An SF, Giometto B, Groves M, Miller RF, Beckett AA, Gray F, et al. Axonal damage revealed by accumulation of beta-APP in HIV-positive individuals without AIDS. J Neuropathol Exp Neurol 1997; 56: 1262-8.
8. Anthony DC, Ferguson B, Matyzak MK, Miller KM, Esiri MM, Perry VH. Differential matrix metalloproteinase expression in cases of multiple sclerosis and stroke. Neuropathol Appl Neurobiol 1997; 23: 406-15.
9. Bagasra O, Michaels FH, Zheng YM, Bobroski LE, Spitsin SV, Fu ZF, et al. Activation of the inducible form of nitric oxide synthase in the brains of patients with multiple sclerosis. Proc Natl Acad Sci USA 1995; 92: 12041-5.
10. Banati RB, Newcombe J, Gunn RN, Cagnin A, Turkheimer F, Heppner F, et al. The peripheral benzodiazepine binding site in the brain in multiple sclerosis: quantitative in vivo imaging of microglia as a measure of disease activity. Brain 2000; 123: 2321-37.
11. Banik NL, Matzelle DC, Gantt-Wilford G, Osborne A, Hogan EL. Increased calpain content and progressive degradation of neurofilament protein in spinal cord injury. Brain Res 1997; 752: 301-6.
12. Bitsch A, Schuchardt J, Bunkowski S, Kuhlmann T, Bruck W. Acute axonal injury in multiple sclerosis. Correlation with demyelination and inflammation. Brain 2000; 123: 1174-83.
13. Blumbergs PC, Scott G, Manavis J, Wainwright H, Simpson DA, McLean AJ. Staining of amyloid precursor protein to study axonal damage in mild head injury. Lancet 1994; 344: 1055-6.
14. Blumbergs PC, Scott G, Manavis J, Wainwright H, Simpson DA, McLean AJ. Topography of axonal injury as defined by amyloid precursor protein and the sector scoring method in mild and severe closed head injury. J Neurotrauma 1995; 12: 565-72.
15. Bo L, Dawson TM, Wesselingh S, Mork S, Choi S, Kong PA, et al. Induction of nitric oxide synthase in demyelinating regions of multiple sclerosis brains. Ann Neurol 1994; 36: 778-86.
16. Bozzali M, Falini A, Franceschi M, Cercignani M, Zuffi M, Scotti G, et al. White matter damage in Alzheimer's disease assessed in vivo using diffusion tensor magnetic resonance imaging. J Neurol Neurosurg Psychiatry 2002; 72: 742-6.
17. Brück W, Sommermeier N, Bergmann M, Zettl U, Goebel HH, Kretzschmar H, et al. Macrophages in multiple sclerosis. Immunobiology 1996; 195: 588-600.
18. Büki A, Okonkwo DO, Wang KK, Povlishock JT. Cytochrome c release and caspase activation in traumatic axonal injury. J Neurosci 2000; 20: 2825-34.
19. Case ME, Graham MA, Handy TC, Jentzen JM, Monteleone JA. Position paper on fatal abusive head injuries in infants and young children. Am J Forensic Med Pathol 2001; 22: 112-22.
20. Chandler S, Coates R, Gearing A, Lury J, Wells G, Bone E. Matrix metalloproteinases degrade myelin basic protein. Neurosci Lett 1995; 201: 223-6.
21. Davie CA, Hawkins CP, Barker GJ, Brennan A, Tofts PS, Miller DH, et al. Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions. Brain 1994; 117: 49-58.
22. Davis TM, Suputtamongkol Y, Spencer JL, Ford S, Chienkul N, Schulenburg WE, et al. Measures of capillary permeability in acute falciparum malaria: relation to severity of infection and treatment. Clin Infect Dis 1992; 15: 256-66.
23. De Groot CJ, Langeveld CH, Jongenelen CA, Montagne L, Van Der Valk P, Dijkstra CD. Establishment of human adult astrocyte cultures derived from postmortem multiple sclerosis and control brain and spinal cord regions: immunophenotypical and functional characterization. J Neurosci Res 1997; 49: 342-54.
24. Dolinak D, Smith C, Graham DI. Hypoglycaemia is a cause of axonal injury. Neuropathol Appl Neurobiol 2000a; 26: 448-53.
25. Dolinak D, Smith C, Graham DI. Global hypoxia per se is an unusual cause of axonal injury. Acta Neuropathol (Berl) 2000b; 100:553-60.
26. Dugbartey AT, Spellacy FJ, Dugbartey MT. Somatosensory discrimination deficits following pediatric cerebral malaria. Am J Trop Med Hyg 1998; 59: 393-6.
27. Dumont RJ, Okonkwo DO, Verma S, Hurlbert RJ, Boulos PT, Ellegala DB, Dumont AS. Acute spinal cord injury, part I: pathophysiologic mechanisms. Clin Neuropharmacol 2001; 24: 254-64.
28. Eidelberg E, Story JL, Walden JG, Meyer BL. Anatomical correlates of return of locomotor function after partial spinal cord lesions in cats. Exp Brain Res 1981; 42: 81-8.
29. Esiri MM, Wilcock GK, Morris JH. Neuropathological assessment of the lesions of significance in vascular dementia. J Neurol Neurosurg Psychiatry 1997; 63: 749-55.
30. Esiri MM, Mathews F, Brayne C, Ince PG for CFAS. Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Lancet 2001; 357: 169-75.
31. Evangelou N, Esiri MM, Smith S, Palace J, Matthews PM. Quantitative pathological evidence for axonal loss in normal appearing white matter in multiple sclerosis. Ann Neurol 2000a; 47: 391-5.
32. Evangelou N, Konz D, Esiri MM, Smith S, Palace J, Matthews PM. Regional axonal loss in the corpus callosum correlates with cerebral white matter lesion volume and distribution in multiple sclerosis. Brain 2000b; 123: 1845-9.
33. Evangelou N, Konz D, Esiri MM, Smith S, Palace J, Matthews PM. Size-selective neuronal changes in the anterior optic pathways suggest a differential susceptibility to injury in multiple sclerosis. Brain 2001; 124: 1813-20.
34. Fehlings MG, Tator CH. The relationships among the severity of spinal cord injury, residual neurological function, axon counts, and counts of retrogradely labeled neurons after experimental spinal cord injury. Exp Neurol 1995; 132: 220-8.
35. Ferguson B, Matyszak MK, Esiri MM, Perry VH. Axonal damage in acute multiple sclerosis lesions. Brain 1997; 120: 393-9.
36. Fink DJ, Datta S, Mata M. Isoform specific reductions in Na+,K(+)-ATPase catalytic (alpha) subunits in the nerve of rats with streptozotocin-induced diabetes. J Neurochem 1994; 63: 1782-6.
37. Fisher E, Rudick RA, Cutter G, Baier M, Miller D, Weinstock-Guttman B, et al. Relationship between brain atrophy and disability: an 8-year follow-up study of multiple sclerosis patients. Mult Scler 2000; 6: 373-7.
38. Fitzpatrick MO, Dewar D, Teasdale GM, Graham DI. The neuronal cytoskeleton in acute brain injury. [Review]. Br J Neurosurg 1998; 12: 313-7.
39. Ganter P, Prince C, Esiri MM. Spinal cord axonal loss in multiple sclerosis: a post-mortem study. Neuropathol Appl Neurobiol 1999; 25: 459-67.
40. Garthwaite G, Goodwin DA, Batchelor AM, Leeming K, Garthwaite J. Nitric oxide toxicity in CNS white matter: an in vitro study using rat optic nerve. Neuroscience 2002; 109: 145-55.
41. Geddes JF, Vowles GH, Beer TW, Ellison DW. The diagnosis of diffuse axonal injury: implications for forensic practice. Neuropathol Appl Neurobiol 1997; 23: 339-47.
42. Geddes JF, Whitwell HL, Graham DI. Traumatic or diffuse axonal injury? Author's response. Neuropathol Appl Neurobiol 2000; 26: 491.
43. Geddes JF, Hackshaw AK, Vowles GH, Nickols CD, Whitwell HL. Neuropathology of inflicted head injury in children. I. Patterns of brain damage. Brain 2001a; 124: 1290-8.
44. Geddes JF, Vowles GH, Hackshaw AK, Nickols CD, Scott IS, Whitwell HL. Neuropathology of inflicted head injury in children. II. Microscopic brain injury in infants. Brain 2001b; 124: 1299-306.
45. Genain CP, Cannella B, Hauser SL, Raine CS. Identification of autoantibodies associated with myelin damage in multiple sclerosis. Nat Med 1999; 5: 170-5.
46. Gennarelli TA, Thibault LE, Adams JH, Graham DI, Thompson CJ, Marcincin RP. Diffuse axonal injury and traumatic coma in the primate. Ann Neurol 1982; 12: 564-74.
47. Gentleman SM, Nash MJ, Sweeting CJ, Graham DI, Roberts GW. Beta-amyloid precursor protein (beta APP) as a marker for axonal injury after head injury. Neurosci Lett 1993; 160: 139-44.
48. Gentleman SM, Roberts GW, Gennarelli TA, Maxwell WL, Adams JH, Kerr S, et al. Axonal injury: a universal consequence of fatal closed head injury? Acta Neuropathol (Berl) 1995; 89: 537-43.
49. Gijbels K, Proost P, Masure S, Carton H, Billiau A, Opdenakker G. Gelatinase B is present in the cerebrospinal fluid during experimental autoimmune encephalomyelitis and cleaves myelin basic protein. J Neurosci Res 1993; 36: 432-40.
50. Giometto B, An SF, Groves M, Scaravilli T, Geddes JF, Miller R, et al. Accumulation of beta-amyloid precursor protein in HIV encephalitis: relationship with neuropsychological abnormalities. Ann Neurol 1997; 42: 34-40.
51. Giovannoni G, Miller RF, Heales SJ, Land JM, Harrison MJ, Thompson EJ. Elevated cerebrospinal fluid and serum nitrate and nitrite levels in patients with central nervous system complications of HIV-1 infection: a correlation with blood-brain barrier dysfunction. J Neurol Sci 1998; 156: 53-8.
52. Giulian D, Vaca K, Corpuz M. Brain glia release factors with opposing actions upon neuronal survival. J Neurosci 1993; 13: 29-37.
53. Gonzalez RG, Ruiz A, Tracey I, McConnell J. Structural, functional, and molecular neuroimaging in AIDS. In: Gendelman H, Lipton SA, Epstein L, Swindells S, editors. The neurology of AIDS. New York: Chapman and Hall; 1998. p. 333-52.
54. Grady MS, McLaughlin MR, Christman CW, Valadka AB, Fligner CL, Povlishock JT. The use of antibodies targeted against the neurofilament subunits for the detection of diffuse axonal injury in humans. J Neuropathol Exp Neurol 1993; 52: 143-52.
55. Graham DI, McLellan D, Adams JH, Doyle D, Kerr A, Murray LS. The neuropathology of the vegetative state and severe disability after non-missile head injury. Acta Neurochir (Wien) Suppl 1983; 32: 65-7.
56. Gray F, Belec L, Chretien F, Dubreuil-Lemaire ML, Ricolfi F, Wingertsmann L, et al. Acute, relapsing brain oedema with diffuse blood-brain barrier alteration and axonal damage in the acquired immunodeficiency syndrome. Neuropathol Appl Neurobiol 1998; 24: 209-16.
57. Greenfield JG, King LS. Observations on the histopathology of the cerebral lesions in disseminated sclerosis. Brain 1936; 59: 445-58.
58. Grimaud J, Barker GJ, Wang L, Lai M, MacManus DG, Webb SL, et al. Correlation of magnetic resonance imaging parameters with clinical disability in multiple sclerosis: a preliminary study. J Neurol 1999; 246: 961-7.
59. Gultekin SH, Smith TW. Diffuse axonal injury in craniocerebral trauma. A comparative histologic and immunohistochemical study. Arch Pathol Lab Med 1994; 118: 168-71.
60. Gveric D, Hanemaaijer R, Newcombe J, van Lent NA, Sier CF, Cuzner ML. Plasminogen activators in multiple sclerosis lesions: implications for the inflammatory response and axonal damage. Brain 2001; 124: 1978-88.
61. Hsu KS, Liang YC, Huang CC. Influence of an extracellular acidosis on excitatory synaptic transmission and long-term potentiation in the CA1 region of rat hippocampal slices. J Neurosci Res 2000; 62: 403-15.
62. Inzitari D, Romanelli M, Pantoni L. Leukoaraiosis and cognitive impairment. In: O'Brien J, Ames D, Burns A, editor. Dementia. 2nd ed. London: Arnold; 2000. p. 635-53.
63. Jane JA, Steward O, Gennarelli T. Axonal degeneration induced by experimental noninvasive minor head injury. J Neurosurg 1985; 62: 96-100.
64. Joutel A, Andreux F, Gaulis S, Domenga V, Cecillon M, Battail N, et al. The ectodomain of the Notch3 receptor accumulates within the cerebrovasculature of CADASIL patients. J Clin Invest 2000; 105: 597-605.
65. Kapoor R, Davies M, Baker P, Hall SM, Smith KJ. Blockers of sodium and calcium entry protect axons from nitric oxide-mediated degeneration. Ann Neurol 2002; DOI10.102/ana.10443.
66. Kaur B, Rutty GN, Timperley WR. The possible role of hypoxia in the formation of axonal bulbs. J Clin Pathol 1999; 52: 203-9.
67. Kinney HC, Samuels MA. Neuropathology of the persistent vegetative state. [Review]. J Neuropathol Exp Neurol 1994; 53: 548-58.
68. Kochar DK, Makkar RK. Somatosensory evoked potentials in cerebral malaria. A preliminary study. Electromyogr Clin Neurophysiol 1994; 34: 301-7.
69. Kornek B, Lassmann H. Axonal pathology in multiple sclerosis. A historical note. Brain Pathol 1999; 9: 651-6.
70. Kornek B, Storch MK, Weissert R, Wallstroem E, Stefferl A, Olsson T, et al. Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions. Am J Pathol 2000; 157: 267-76.
71. Kornek B, Storch MK, Bauer J, Djamshidian A, Weissert R, Wallstroem E, et al. Distribution of a calcium channel subunit in dystrophic axons in multiple sclerosis and experimental autoimmune encephalomyelitis. Brain 2001; 124: 1114-24.
72. Kuhlmann T, Lingfeld G, Bitsch A, Schuchardt J, Bruck W. Acute axonal damage in multiple sclerosis is most extensive in early disease stages and decreases over time. Brain 2002; 125: 2202-12.
73. Lake B. Lysosomal and peroxisomal disorders. In: Graham DI, Lantos PL, editors. Greenfield's neuropathology, Vol. 1. London: Arnold; 1997. p. 658-753.
74. Lawrence DM, Major EO. HIV-1 and the brain: connections between HIV-1-associated dementia, neuropathology and neuroimmunology. [Review]. Microbes Infect 2002; 4: 301-8.
75. Leppert D, Lindberg RL, Kappos L, Leib SL. Matrix metalloproteinases: multifunctional effectors of inflammation in multiple sclerosis and bacterial meningitis. [Review]. Brain Res Brain Res Rev 2001; 36: 249-57.
76. Levin MC, Lee SM, Kalume F, Morcos Y, Dohan FC, Hasty KA, et al. Autoimmunity due to molecular mimicry as a cause of neurological disease. Nat Med 2002; 8: 509-13.
77. Lewallen S, Harding SP, Ajewole J, Schulenburg WE, Molyneux ME, Marsh K, et al. A review of the spectrum of clinical ocular fundus findings in P. falciparum malaria in African children with a proposed classification and grading system. Trans R Soc Trop Med Hyg 1999; 93: 619-22.
78. Li GL, Farooque M, Holtz A, Olsson Y. Changes of beta-amyloid precursor protein after compression trauma to the spinal cord: an experimental study in the rat using immunohistochemistry. J Neurotrauma 1995; 12: 269-77.
79. Lindberg RL, De Groot CJ, Montagne L, Freitag P, van der Valk P, Kappos L, et al. The expression profile of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in lesions and normal appearing white matter of multiple sclerosis. Brain 2001; 124: 1743-53.
80. Lindenberg R, Freytag E. Brainstem lesions characteristic of traumatic hyperextension of the head. Arch Pathol 1970; 90: 509-15.
81. Liu D, Smith CL, Barone FC, Ellison JA, Lysko PG, Li K, et al. Astrocytic demise precedes delayed neuronal death in focal ischemic rat brain. Brain Res Mol Brain Res 1999; 68: 29-41.
82. LoPachin RMJ, Lehning EJ. Acrylamide-induced distal axon degeneration: a proposed mechanism of action. [Review]. Neurotoxicology 1994; 15: 247-59.
83. LoPachin RM Jr, Lehning EJ. Mechanism of calcium entry during axon injury and degeneration. [Review]. Toxicol Appl Pharmacol 1997; 143: 233-44.
84. Lovas G, Szilagyi N, Majtenyi K, Palkovits M, Komoly S. Axonal changes in chronic demyelinated cervical spinal cord plaques. Brain 2000; 123: 308-17.
85. Mankowski JL, Queen SE, Tarwater PM, Fox KJ, Perry VH. Accumulation of beta-amyloid precursor protein in axons correlates with CNS expression of SIV gp41. J Neuropathol Exp Neurol 2002; 61: 85-90.
86. Manning PT, Johnson EM Jr, Wilcox CL, Palmatier MA, Russell JH. MHC-specific cytotoxic T lymphocyte killing of dissociated sympathetic neuronal cultures. Am J Pathol 1987; 128: 395-409.
87. Masliah E, Achim CL, Ge N, DeTeresa R, Terry RD, Wiley CA. Spectrum of human immunodeficiency virus-associated neocortical damage. Ann Neurol 1992; 32: 321-9.
88. Matthews PM, De Stefano N, Narayanan S, Francis GS, Wolinsky JS, Antel JP, et al. Putting magnetic resonance spectroscopy studies in context: axonal damage and disability in multiple sclerosis. [Review]. Semin Neurol 1998; 18: 327-36.
89. Maxwell WL, Povlishock JT, Graham DL. A mechanistic analysis of nondisruptive axonal injury: a review. [Review]. J Neurotrauma 1997; 14: 419-40.
90. McKenzie KJ, McLellan DR, Gentleman SM, Maxwell WL, Gennarelli TA, Graham DI. Is beta-APP a marker of axonal damage in short-surviving head injury? Acta Neuropathol (Berl) 1996; 92: 608-13.
91. McLeod D, Marshall J, Kohner EM, Bird AC. The role of axoplasmic transport in the pathogenesis of retinal cotton-wool spots. Br J Ophthalmol 1977; 61: 177-91.
92. Medana IM, Martinic M, Wekerle H, Neumann H. Transection of major histocompatibility complex class I-induced neurites by cytotoxic T lymphocytes. Am J Pathol 2001; 159: 809-15.
93. Medana I, Day NP, Hien TT, Mai NT, Bethell D, Phu NH, et al. Axonal injury in cerebral malaria. Am J Pathol 2002; 160: 655-66.
94. Mews I, Bergmann M, Bunkowski S, Gullotta F, Bruck W. Oligodendrocyte and axon pathology in clinically silent multiple sclerosis lesions. Mult Scler 1998; 4: 55-62.
95. Nashmi R, Fehlings MG. Changes in axonal physiology and morphology after chronic compressive injury of the rat thoracic spinal cord. Neuroscience 2001a; 104: 235-51.
96. Nashmi R, Fehlings MG. Mechanisms of axonal dysfunction after spinal cord injury: with an emphasis on the role of voltage-gated potassium channels. Brain Res Brain Res Rev [Review]. 2001b; 38: 165-91.
97. Neumann H, Medana IM, Bauer J, Lassmann H. Cytotoxic T lymphocytes in autoimmune and degenerative CNS diseases. Trends Neurosci 2002; 25: 313-9.
98. Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study(MRC CFAS). Neuropathological assessment of the lesions of significance in vascular dementia. J Neurol Neurosurg Psychiatry 1997; 63: 749-53.
99. Newman TA, Woolley ST, Hughes PM, Sibson NR, Anthony DC, Perry VH. T-cell- and macrophage-mediated axon damage in the absence of a CNS-specific immune response: involvement of metalloproteinases. Brain 2001; 124: 2203-14.
100. Newton CR, Hien TT, White N. Cerebral malaria. [Review]. J Neurol Neurosurg Psychiatry 2000; 69: 433-41
101. Ng HK, Mahaliyana RD, Poon WS. The pathological spectrum of diffuse axonal injury in blunt head trauma: assessment with axon and myelin strains. Clin Neurol Neurosurg 1994; 96: 24-31.
102. Oehmichen M, Meissner C, Schmidt V, Pedal I, Konig HG, Saternus KS. Axonal injury - a diagnostic tool in forensic neuropathology? A review. Forensic Sci Int 1998; 95: 67-83.
103. Oppenheimer DR. Microscopic lesions in the brain following head injury. J Neurol Neurosurg Psychiatry 1968; 31: 299-306.
104. Paolillo A, Pozzilli C, Gasperini C, Giugni E, Mainero C, Giuliani S, et al. Brain atrophy in relapsing-remitting multiple sclerosis: relationship with 'black holes', disease duration and clinical disability. J Neurol Sci 2000; 174: 85-91.
105. Pelletier J, Suchet L, Witjas T, Habib M, Guttmann CR, Salamon G, et al. A longitudinal study of callosal atrophy and interhemispheric dysfunction in relapsing-remitting multiple sclerosis. Arch Neurol 2001; 58: 105-11.
106. Pesini P, Kopp J, Wong H, Walsh JH, Grant G, Hokfelt T. An immunohistochemical marker for Wallerian degeneration of fibers in the central and peripheral nervous system. Brain Res 1999; 828: 41-59.
107. Povlishock JT, Becker DP, Cheng CL, Vaughan GW. Axonal change in minor head injury. J Neuropathol Exp Neurol 1983; 42: 225-42.
108. Powers JM, Moser HW. Peroxisomal disorders: genotype, phenotype, major neuropathologic lesions, and pathogenesis. [Review]. Brain Pathol 1998; 8: 101-20.
109. Putnam TJ. Studies in multiple sclerosis. Arch Neurol Psychiat 1936; 35: 1289-308.
110. Raja F, Sherriff FE, Morris CS, Bridges LR, Esiri MM. Cerebral white matter damage in HIV infection demonstrated using beta-amyloid precursor protein immunoreactivity. Acta Neuropathol (Berl) 1997; 93: 184-9.
111. Rawes JA, Calabrese VP, Khan OA, DeVries GH. Antibodies to the axolemma-enriched fraction in the cerebrospinal fluid and serum of patients with multiple sclerosis and other neurological diseases. Mult Scler 1997; 3: 363-9.
112. Ray SK, Matzelle DD, Wilford GG, Hogan EL, Banik NL. Cell death in spinal cord injury (SCI) requires de novo protein synthesis. Calpain inhibitor E-64-d provides neuroprotection in SCI lesion and penumbra. Ann NY Acad Sci 2001; 939: 436-49.
113. Rosenberg LJ, Teng YD, Wrathall JR. Effects of the sodium channel blocker tetrodotoxin on acute white matter pathology after experimental contusive spinal cord injury. J Neurosci 1999; 19: 6122-33.
114. Saido TC, Sorimachi H, Suzuki K. Calpain: new perspectives in molecular diversity and physiological-pathological involvement. [Review]. FASEB J 1994; 8: 814-22.
115. Schaumburg HH, Powers JM, Raine CS, Suzuki K, Richardson EP Jr. Adrenoleukodystrophy. A clinical and pathological study of 17 cases. Arch Neurol 1975; 32: 577-91.
116. Schumacher PA, Eubanks JH, Fehlings MG. Increased calpain I-mediated proteolysis, and preferential loss of dephosphorylated NF200, following traumatic spinal cord injury. Neuroscience 1999; 91: 733-44.
117. Schumacher PA, Siman RG, Fehlings MG. Pretreatment with calpain inhibitor CEP-4143 inhibits calpain I activation and cytoskeletal degradation, improves neurological function, and enhances axonal survival after traumatic spinal cord injury. J Neurochem 2000; 74: 1646-55.
118. Sherriff FE, Bridges LR, Gentleman SM, Sivaloganathan S, Wilson S. Markers of axonal injury in post mortem human brain. Acta Neuropathol (Berl) 1994a; 88: 433-9.
119. Sherriff FE, Bridges LR, Sivaloganathan S. Early detection of axonal injury after human head trauma using immunocytochemistry for beta-amyloid precursor protein. Acta Neuropathol (Berl) 1994b; 87: 55-62.
120. Simon JH, Kinkel RP, Jacobs L, Bub L, Simonian N. A Wallerian degeneration pattern in patients at risk for MS. Neurology 2000; 54: 1155-60.
121. Simpson DA, Blumbergs PC, Cooter RD, Kilminster M, McLean AJ, Scott G. Pontomedullary tears and other gross brainstem injuries after vehicular accidents. J Trauma 1989; 29: 1519-25.
122. Skoog I, Berg S, Johansson B, Palmertz B, Andreasson LA. The influence of white matter lesions on neuropsychological functioning in demented and non-demented 85-year-olds. Acta Neurol Scand 1996; 93: 142-8.
123. Sloviter RS, Dean E, Sollas AL, Goodman JH. Apoptosis and necrosis induced in different hippocampal neuron populations by repetitive perforant path stimulation in the rat. J Comp Neurol 1996; 366: 516-33.
124. Smith DH, Nonaka M, Miller R, Leoni M, Chen XH, Alsop D, et al. Immediate coma following inertial brain injury dependent on axonal damage in the brainstem. J Neurosurg 2000; 93: 315-22.
125. Smith KJ, Kapoor R, Hall SM, Davies M. Electrically active axons degenerate when exposed to nitric oxide. Ann Neurol 2001; 49: 470-6.
126. Springer JE, Azbill RD, Kennedy SE, George J, Geddes JW. Rapid calpain I activation and cytoskeletal protein degradation following traumatic spinal cord injury: attenuation with riluzole pretreatment. J Neurochem 1997; 69: 1592-600.
127. Strich SSJ. Diffuse degeneration of the cerebral white matter in severe dementia following hand injury. J Neurol Neurosurg Psychiatry 1956; 19: 163-85.
128. Stys PK. Anoxic and ischemic injury of myelinated axons in CNS white matter: from mechanistic concepts to therapeutics. [Review]. J Cereb Blood Flow Metab 1998; 18: 2-25.
129. Suenaga T, Ohnishi K, Nishimura M, Nakamura S, Akiguchi I, Kimura J. Bundles of amyloid precursor protein-immunoreactive axons in human cerebrovascular white matter lesions. Acta Neuropathol (Berl) 1994; 87: 450-5.
130. Tavalin SJ, Ellis EF, Satin LS. Inhibition of the electrogenic Na pump underlies delayed depolarization of cortical neurons after mechanical injury or glutamate. J Neurophysiol 1997; 77: 632-8.
131. Teahan O, Slade JY, Perry RH, Ballard CG, Kalaria RN. White matter pathology in Alzheimer's disease and vascular dementia: quantification by amyloid-beta precursor protein immunocytochemistry [abstract]. Neuropathol Appl Neurobiol 2002; 28: 168.
132. Teng YD, Wrathall JR. Local blockade of sodium channels by tetrodotoxin ameliorates tissue loss and long-term functional deficits resulting from experimental spinal cord injury. J Neurosci 1997; 17: 4359-66.
133. Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mork S, Bo L. Axonal transection in the lesions of multiple sclerosis. New Engl J Med 1998; 338: 278-85.
134. Turner G. Cerebral malaria. [Review]. Brain Pathol 1997; 7: 569-82.
135. Umehara F, Abe M, Koreeda Y, Izumo S, Osame M. Axonal damage revealed by accumulation of beta-amyloid precursor protein in HTLV-I-associated myelopathy. J Neurol Sci 2000; 176: 95-101.
136. Vinters HV, Ellis WG, Zarow C, Zaias BW, Jagust WJ, Mack WJ, et al. Neuropathologic substrates of ischemic vascular dementia. [Review]. J Neuropathol Exp Neurol 2000; 59: 931-45.
137. Wang KK, Posmantur R, Nadimpalli R, Nath R, Mohan P, Nixon RA, et al. Caspase-mediated fragmentation of calpain inhibitor protein calpastatin during apoptosis. Arch Biochem Biophys 1998; 356: 187-96.
138. Weis S, Jellinger K, Wenger E. Morphometry of the corpus callosum in normal aging and Alzheimer's disease. J Neural Transm Suppl 1991; 33: 35-8.
139. White L, Petrovich H, Hardman J, Nelson J, Davis DG, Ross G-W, et al. Cerebrovascular pathology and impaired cognitive function in autopsied Honolulu-Asia aging study participants. Ann NY Acad Sci 2002; 977: 9-23.
140. Wolf JA, Stys PK, Lusardi T, Meaney D, Smith DH. Traumatic axonal injury induces calcium influx modulated by tetrodotoxin-sensitive sodium channels. J Neurosci 2001; 21: 1923-30.
141. Wujek JR, Bjartmar C, Richer E, Ransohoff RM, Yu M, Tuohy VK, et al. Axon loss in the spinal cord determines permanent neurological disability in an animal model of multiple sclerosis. J Neuropathol Exp Neurol 2002; 61: 23-32.
142. Zimmerman RA, Bilaniuk LT. Pediatric head trauma. [Review]. Neuroimaging Clin N Am 1994; 4: 349-66.
143. Ziv NE, Spira ME. Axotomy induces a transient and localized elevation of the free intracellular calcium concentration to the millimolar range. J Neurophysiol 1995; 74: 2625-37.